Clostridium butyricum and its metabolite butyrate promote ferroptosis susceptibility in pancreatic ductal adenocarcinoma
- 1 June 2023
- journal article
- research article
- Published by Springer Nature in Cellular Oncology
- Vol. 46 (6) , 1645-1658
Abstract
Purpose Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive disease with limited therapeutic options. The diversity and composition of the intratumoral microbiota are associated with PDAC outcomes, and modulating the tumor microbiota has the potential to influence tumor growth and the host immune response. Here, we explore whether intervention with butyrate-producing probiotics can limit PDAC progression. Methods Based on the TCGA (PAAD) database, we analyzed the differential communities of intratumoral microbiota in PDAC patients with long survival and short survival and explored the relevant mechanisms of Clostridium butyricum and its metabolite butyrate in the treatment of PDAC. Treatment with Clostridium butyricum or butyrate in combination with the ferroptosis inducer RSL3 in a PDAC mouse model has an inhibitory effect on PDAC progression. The potential molecular mechanisms were verified by flow cytometry, RNA-seq, Western blotting, qRT‒PCR and immunofluorescence. Results We found that the tumoral butyrate-producing microbiota was linked to a better prognosis and less aggressive features of PDAC. Intervention with Clostridium butyricum or its metabolite butyrate triggered superoxidative stress and intracellular lipid accumulation, which enhanced ferroptosis susceptibility in PDAC. Conclusion Our study reveals a novel antitumor mechanism of butyrate and suggests the therapeutic potential of butyrate-producing probiotics in PDAC.Keywords
This publication has 45 references indexed in Scilit:
- Possible involvement of Enterococcus infection in the pathogenesis of chronic pancreatitis and cancerBiochemical and Biophysical Research Communications, 2018
- IL22RA1/STAT3 Signaling Promotes Stemness and Tumorigenicity in Pancreatic CancerCancer Research, 2018
- The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune SuppressionCancer Discovery, 2018
- Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabineScience, 2017
- Cancer Manipulation of Host Physiology: Lessons from Pancreatic CancerTrends in Molecular Medicine, 2017
- From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial MetabolitesCell, 2016
- Revealing the Bacterial Butyrate Synthesis Pathways by Analyzing (Meta)genomic DatamBio, 2014
- Lipolysis and lipid mobilization in human adipose tissueProgress in Lipid Research, 2009
- CuZn-SOD Deficiency Causes ApoB Degradation and Induces Hepatic Lipid Accumulation by Impaired Lipoprotein Secretion in MiceJournal of Biological Chemistry, 2006
- Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice.Proceedings of the National Academy of Sciences, 1996